TWi Pharmaceuticals, Inc. (“TWi”) today announced that its ANDA (“Abbreviated New Drug Application”) for Dicyclomine Hydrochloride Capsule (equivalent to BENTYL ®) has been officially approved by US FDA. The Company will start the preparation for launch in the US market accordingly.
